An open prospective randomized control clinical trial for evaluation of efficacy and safety of LifePort Kidney Transporter on DCD kidney hypothermia preservation

Clinical and experimental research for improving organ quality from donation after cardiac death

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003528

Enrollment

Unknown

Registered

2013-08-21

Start date

2013-09-16

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preservation of kidney graft

Interventions

LifePort group:Hypothermia preserve DCD kidneys by LifeoPort Transporter

Control:Rutine method

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. The recipient sign the consent for atteding this clinical trial; 2. donor aged from 16 to 60 years old; 3. kidney from dontion after cardiac death; 4. Ricipient age =18 years old and <65 years old; 5. First transplant, and PRA negative before transplant.

Exclusion criteria

Exclusion criteria: 1. Multiple arteries on both side of donor kidneys; 2. Donor has only one kidney; 3. Donor is infected by HBV, HCV, syphilis or HIV; 4. One side or both sides of donor kidneys have calculus, tuberculosis,infection, or malignant tumors; 5. Secondary kidney transplant, or multi-organ transplant; 6. Recipient die within first weeek after transplantion; 7. Recipient is a pregnant or lactation woman, or have mental disorders.

Design outcomes

Primary

Measure	Time frame
Delayed graft function;	—

Countries

China

Contacts

Public ContactHE XIAOSHUN

gdtrc@163.com+86 13802510799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026